5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Malignant Mesothelioma in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mesothelioma is a neoplastic disease associated with asbestos exposure." | 1.91 | Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations. ( Akao, K; Mukai, S; Sato, A; Sato, T; Sekido, Y; Tsujimura, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, T | 1 |
| Akao, K | 1 |
| Sato, A | 1 |
| Tsujimura, T | 1 |
| Mukai, S | 1 |
| Sekido, Y | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Malignant Mesothelioma
| Article | Year |
|---|---|
Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations.
Topics: Hippo Signaling Pathway; Humans; Mesothelioma; Mesothelioma, Malignant; Pleural Effusion; Protein Se | 2023 |